There were 1,750 press releases posted in the last 24 hours and 430,095 in the last 365 days.

The Worldwide Therapeutic Vaccines Industry is Expected to Reach $107.4 Billion by 2027 - ResearchAndMarkets.com

DUBLIN, January 07, 2022 /BUSINESS WIRE/ --

The "Therapeutic Vaccines - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Therapeutic Vaccines estimated at US$24.6 Billion in the year 2020, is projected to reach a revised size of US$107.4 Billion by 2027, growing at a CAGR of 23.5% over the period 2020-2027.

The U.S. Market is Estimated at $6.6 Billion, While China is Forecast to Grow at 29.3% CAGR

The Therapeutic Vaccines market in the U.S. is estimated at US$6.6 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$26.2 Billion by the year 2027 trailing a CAGR of 29.3% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.5% and 21.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 20.1% CAGR.

Select Competitors (Total 43 Featured):

  • Agenus, Inc.
  • Bavarian Nordic A/S
  • CEL-SCI Corporation
  • Dendreon Corporation
  • GlaxoSmithKline PLC
  • Novartis International AG
  • Oncothyreon, Inc.
  • TVAX Biomedical Inc.
  • Vical, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/arbbwt

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.